Lars Iversen Selected Research

Etanercept (Enbrel)

10/2016	Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis.
12/2009	Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Iversen Research Topics

Disease

74	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 11/2003
19	Inflammation (Inflammations) 01/2023 - 01/2005
16	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 12/2023 - 06/2007
13	Neoplasms (Cancer) 01/2024 - 06/2007
10	Mycosis Fungoides 12/2023 - 01/2006
9	Skin Diseases (Skin Disease) 08/2021 - 01/2005
6	Allergic Contact Dermatitis 11/2013 - 10/2004
5	Atopic Dermatitis (Atopic Eczema) 11/2023 - 08/2010
5	Contact Dermatitis (Eczema, Contact) 11/2013 - 10/2004
4	Psoriatic Arthritis 12/2023 - 01/2021
3	Hidradenitis Suppurativa 12/2023 - 01/2021
3	Disease Progression 01/2022 - 08/2013
3	Necrosis 02/2021 - 01/2008
3	Carcinogenesis 03/2016 - 01/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 01/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2008 - 11/2005
2	Heart Failure 06/2008 - 11/2005
1	Leukocytosis (Pleocytosis) 11/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2023

Drug/Important Bio-Agent (IBA)

23	CytokinesIBA 04/2024 - 01/2005
15	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2005
14	Interleukin-17 (Interleukin 17)IBA 04/2024 - 07/2011
10	MicroRNAs (MicroRNA)IBA 10/2022 - 12/2014
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023 - 02/2006
6	p38 Mitogen-Activated Protein KinasesIBA 01/2023 - 06/2007
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2008
5	secukinumabIBA 04/2024 - 01/2020
5	Adalimumab (Humira)FDA Link 06/2021 - 12/2009
5	NF-kappa B (NF-kB)IBA 09/2007 - 11/2003
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2013
4	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2019
4	ChemokinesIBA 11/2023 - 01/2005
4	calcipotriene (calcipotriol)FDA LinkGeneric 10/2023 - 10/2020
4	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 10/2023 - 10/2020
4	Imiquimod (Aldara)FDA LinkGeneric 11/2020 - 10/2015
4	Phosphotransferases (Kinase)IBA 01/2020 - 08/2007
4	interleukin 20 (IL-20)IBA 01/2016 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 01/2005
3	Enterotoxins (Enterotoxin)IBA 01/2024 - 07/2014
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2023 - 01/2023
3	Interleukin-23 (Interleukin 23)IBA 12/2023 - 01/2021
3	AntibodiesIBA 11/2023 - 01/2016
3	Prostaglandins AIBA 09/2023 - 10/2016
3	brodalumabIBA 06/2023 - 11/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
3	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2015
3	Ustekinumab (CNTO 1275)FDA Link 10/2016 - 03/2013
3	OxazoloneIBA 11/2013 - 04/2009
3	NickelIBA 10/2011 - 10/2004
3	CaspasesIBA 08/2009 - 12/2007
2	Monoclonal AntibodiesIBA 04/2024 - 11/2017
2	tofacitinibIBA 12/2023 - 10/2016
2	Janus Kinase InhibitorsIBA 12/2023 - 10/2016
2	InterleukinsIBA 09/2023 - 02/2021
2	Ointments (Pastes)IBA 01/2023 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2008
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 04/2017
2	Circular RNAIBA 01/2022 - 11/2019
2	Immunomodulating AgentsIBA 01/2022 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2019
2	Biosimilar PharmaceuticalsIBA 06/2021 - 01/2021
2	ixekizumabIBA 04/2021 - 11/2017
2	ThioredoxinsIBA 01/2021 - 09/2020
2	Peptides (Polypeptides)IBA 01/2020 - 11/2013
2	Dimethyl FumarateIBA 01/2020 - 10/2018
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 01/2017
2	Etanercept (Enbrel)FDA Link 10/2016 - 12/2009
2	Infliximab (Remicade)FDA Link 10/2016 - 12/2009
2	Protein Kinases (Protein Kinase)IBA 01/2015 - 03/2011
2	Antimicrobial PeptidesIBA 03/2014 - 07/2013
2	Protein Isoforms (Isoforms)IBA 05/2011 - 08/2010
2	InflammasomesIBA 03/2011 - 11/2008
2	Caspase 1 (ICE Protease)IBA 08/2009 - 12/2007
2	ragaglitazarIBA 01/2008 - 01/2005
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2008 - 01/2005
1	AminopeptidasesIBA 04/2024
1	guselkumabIBA 12/2023
1	tildrakizumabIBA 12/2023
1	risankizumabIBA 12/2023
1	Filaggrin ProteinsIBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	Immunoglobulin G (IgG)IBA 11/2023
1	LigandsIBA 11/2023
1	Immunoglobulin M (IgM)IBA 11/2023
1	SuspensionsIBA 09/2023
1	RoflumilastIBA 07/2023
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 07/2023
1	Immunoglobulin A (IgA)IBA 05/2023
1	Interleukin-13IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023

Therapy/Procedure

16	Therapeutics 01/2024 - 01/2005
4	Aftercare (After-Treatment) 01/2020 - 01/2016
3	Climatotherapy 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2010
2	Intradermal Injections 11/2020 - 10/2015
2	Biological Therapy 11/2017 - 10/2016
2	Cardiac Rehabilitation 06/2008 - 11/2005
1	Immunomodulation 11/2023
1	Phototherapy (Light Therapy) 05/2023